Lombard Medical, which offers innovative stent-grafts for highly angled endovascular aortic repair, postponed its IPO on Friday, citing poor market conditions. The Oxfordshire, United Kingdom-based company was founded in 2003 and booked $7 million in sales for the 12 months ended 12/31/2013. Lombard Medical initially filed confidentially on 1/22/2014. Jefferies & Co. and Barclays were set to be the joint bookrunners on the deal.
